Development of a strategy to treat limb-girdle muscular dystrophy (LGMD2A) using combined cell and gene therapy strategies

Project Information

LGMD2A

Grant agreement ID: 256512

Project closed

Start date 1 July 2010

End date 29 November 2014

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOA
Spain